10% OffFirst Order? Use code
Back to research database
🔬 General ResearchPublished: August 19, 2026

Selank: Neuroregulatory Heptapeptide Mechanisms, GABAergic Modulation & Brain Plasticity

“Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) is a synthetic regulatory heptapeptide analog of tuftsin developed by the Institute of Molecular Genetics, Russian Academy of Sciences, investigated for non-sedating anxiolysis, hippocampal BDNF expression, and monoaminergic neurotransmission stabilization.”

Consult AnalystResearch Database
Peptide vial product illustration

Legal & Laboratory Compliance Notice

FOR IN-VITRO LABORATORY RESEARCH ONLY: This scientific publication is provided strictly for academic and biochemical reference by certified researchers. Materials and compounds referenced are NOT for human consumption, veterinary use, drug manufacture, or direct clinical administration. Statements have not been evaluated by Health Canada or the FDA.

Scientific Research Overview

Abstract & Executive Summary

Selank (sequence: Thr-Lys-Pro-Arg-Pro-Gly-Pro, MW: 751.89 Da) is a synthetic heptapeptide developed by the Institute of Molecular Genetics and the V.V. Zakusov Institute of Pharmacology of the Russian Academy of Medical Sciences. It was engineered by coupling the endogenous human tetrapeptide tuftsin (TKPR, a peptide produced in the spleen by enzymatic cleavage of IgG heavy chain) with the stabilizing tripeptide Pro-Gly-Pro (PGP).

While classical anxiolytics (such as benzodiazepines) act as direct positive allosteric modulators of GABA_A receptors—causing sedation, muscle relaxation, memory deficits, and physical dependence—Selank operates through gene-regulatory and allosteric modulation of neurotransmitter systems, providing potent anxiolysis paired with nootropic (cognitive-enhancing) properties.

+----------------------------------------------------------------------------------------------------+
|                                      SELANK MULTI-TARGET NEURO-AXIS                                |
+------------------------------------+----------------------------------+-----------------------------+
| GABAergic Gene Expression          | Neurotrophic Plasticity (BDNF)   | Monoamine & Peptide Stability|
| - Modulates α1/β2 GABA_A subunits  | - Upregulates hippocampal BDNF   | - Regulates 5-HT / Dopamine |
| - Restores inhibitory tone         | - Activates TrkB neurogenesis    | - Inhibits enkephalinase    |
| - Zero sedation or myorelaxation   | - Enhances memory consolidation  | - Stabilizes endogenous tone|
+------------------------------------+----------------------------------+-----------------------------+

Chemical Structure & Sequence Architecture

  • Amino Acid Sequence: Thr-Lys-Pro-Arg-Pro-Gly-Pro
  • Single Letter Code: TKPRPGP
  • Molecular Formula: C33H57N11O9
  • Molecular Weight: 751.89 g/mol
  • CAS Registry Number: 129954-34-3
  • The PGP Stabilization Factor: The C-terminal Pro-Gly-Pro sequence creates conformational rigidity that prevents rapid hydrolysis by circulating carboxypeptidases, dipeptidyl peptidases, and aminopeptidases, prolonging central nervous system bioavailability.

    • Mechanism of Action

    Selank influences central nervous system function through four primary molecular pathways:

    1. GABA_A Receptor Subunit Transcriptional Modulation

    Microarray and RT-qPCR studies demonstrate that Selank directly modulates the mRNA transcription of specific GABA_A receptor subunits in the hippocampus and cortex:

  • Enhances transcription of the alpha-1 (GABRA1) and beta-2 (GABRB2) subunits, which are down-regulated during chronic stress and generalized anxiety.
  • This restores balanced inhibitory synaptic tone in hyper-aroused limbic circuits without directly forcing open chloride channels (explaining its lack of sedation or ataxia).

    • 2. Hippocampal BDNF & TrkB Signaling Upregulation

    In rodent models of memory acquisition and stress adaptation:

  • Administration of Selank triggers a rapid, statistically significant elevation in Brain-Derived Neurotrophic Factor (BDNF) mRNA and protein expression in the CA1, CA3, and dentate gyrus regions of the hippocampus.
  • BDNF binds to the Tropomyosin receptor kinase B (TrkB), activating the downstream PI3K/Akt and MAPK/ERK pathways.
  • This stimulates dendritic branching, synaptogenesis, and Long-Term Potentiation (LTP), improving spatial learning and cognitive consolidation.

    • 3. Serotonergic Turnover & Stress Buffering

    Under acute or chronic stress paradigms:

  • Selank stabilizes the metabolic turnover of Serotonin (5-HT) and Dopamine (DA) in the prefrontal cortex and striatum, preventing stress-induced catecholamine depletion.
  • Concurrently modulates 5-HT1A and 5-HT2A receptor expression, buffering against depressive behavioral despair.

    • 4. Inhibition of Enkephalin Degrading Enzymes

    Selank exhibits competitive inhibitory activity against neutral endopeptidases (enkephalinases):

  • Slows the enzymatic breakdown of endogenous enkephalins (met-enkephalin and leu-enkephalin) in human blood serum and brain tissue.
  • Sustains endogenous opioid peptide signaling, elevating stress resilience and modulating emotional responses.

    • Key Study Highlights

    ✓

    Tuftsin-Derived Heptapeptide

    Engineered with a C-terminal Pro-Gly-Pro motif for superior metabolic stability.

    ✓

    Non-Sedating Anxiolysis

    Modulates GABA_A receptor subunit expression without sedative, hypnotic, or motor side effects.

    ✓

    Hippocampal BDNF Upregulation

    Stimulates BDNF-TrkB signaling to support synaptogenesis and long-term potentiation.

    ✓

    Enkephalinase Inhibition

    Slows enzymatic breakdown of endogenous enkephalins, supporting emotional equilibrium.

    Scientific FAQs

    Selank is derived from tuftsin and primarily modulates GABAergic and serotonergic systems for anxiolysis and calm focus. Semax is derived from ACTH(4-10) and primarily modulates dopaminergic and melanocortin systems for stimulation and alertness.
    No. Animal and human studies demonstrate that Selank does not induce tolerance, dependence, withdrawal symptoms, or sedation, as it does not directly bind benzodiazepine allosteric sites.
    Molecular Formula: C33H57N11O9, Molecular Weight: 751.89 g/mol, CAS Number: 129954-34-3.
    Lyophilized Selank powder should be stored at -20°C. Once reconstituted with sterile Bacteriostatic Water or saline, maintain at 2°C to 8°C and use within 28 days.

    References

    1. Volkova A. et al (2016).
      Selank regulates the expression of genes involved in GABAergic neurotransmission in the rat hippocampus
      Front Pharmacol, 7:31
      View Research Paper ↗
    2. Kolomin T. et al (2013).
      Anxiolytic-like effect of Selank and gene expression in the hippocampus
      Neurochem J, 7(4):273-278
      View Research Paper ↗

    Procure Research Reference Materials

    Access laboratory-grade reference compounds with verified batch HPLC purity reports and sterility documentation.

    View Compound Specifications

    Literature Inquiries

    Have questions about the pre-clinical citations or chemical parameters detailed in this research? Connect with our analytical representatives.

    Contact Researchers